Dysmenorrhea Treatment Market

Market Study on Dysmenorrhea Treatment: Rising Focus on Improving the Quality of Life for those Suffering from Menstrual Pain, Heightened Awareness About Menstrual Health, Innovative Pharma Developments, and Increasing Worldwide Focus on Addressing Women's Healthcare Needs

A Detailed Analysis of the Dysmenorrhea Treatment Market Based on Increasing Awareness, and Advancements in Therapeutic Options

- Table of Content -

1. Executive Summary

     1.1. Global Dysmenorrhea Treatment Market Snapshot, 2023 and 2030

     1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn

     1.3. Key Market Trends

     1.4. Future Market Projections

     1.5. Premium Market Insights

     1.6. Industry Developments and Key Market Events

     1.7. PMR Analysis and Recommendations

2. Market Overview

     2.1. Market Scope and Definition

     2.2. Market Dynamics

          2.2.1. Drivers

          2.2.2. Restraints

          2.2.3. Opportunity

          2.2.4. Challenges

          2.2.5. Key Trends

     2.3. Diseases Lifecycle Analysis

     2.4. Dysmenorrhea Treatment Market: Value Chain

          2.4.1. List of Raw Material Supplier

          2.4.2. List of Manufacturers

          2.4.3. List of Distributors

          2.4.4. List of Applications

          2.4.5. Profitability Analysis

     2.5. Porter Five Force’s Analysis

     2.6. Geopolitical Tensions: Market Impact

     2.7. Macro-Economic Factors

          2.7.1. Global Sectorial Outlook

          2.7.2. Global GDP Growth Outlook

          2.7.3. Global Parent Market Overview

     2.8. Forecast Factors - Relevance and Impact

     2.9. Regulatory and Technology Landscape

3. Global Dysmenorrhea Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

     3.1. Key Highlights

          3.1.1. Market Volume (Units) Projections

          3.1.2. Market Size and Y-o-Y Growth

          3.1.3. Absolute $ Opportunity

     3.2. Market Size (US$ Mn) Analysis and Forecast

          3.2.1. Historical Market Size Analysis, 2013-2016

          3.2.2. Current Market Size Forecast, 2018-2026

     3.3. Global Dysmenorrhea Treatment Market Outlook: Diseases

          3.3.1. Introduction / Key Findings

          3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Disease, 2018 - 2022

          3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease, 2023 - 2030

               3.3.3.1. Primary Dysmenorrhea

               3.3.3.2. Secondary Dysmenorrhea

               3.3.3.3. Endometriosis

               3.3.3.4. Adenomyosis

               3.3.3.5. Uterine Myomas

               3.3.3.6. Endometrial Polyps

               3.3.3.7. Cervical Stenosis

               3.3.3.8. Obstructive Malformations of Genital Tract

     3.4. Market Attractiveness Analysis: Diseases

     3.5. Global Dysmenorrhea Treatment Market Outlook: Therapeutic Class

          3.5.1. Introduction / Key Findings

          3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Therapeutic Class, 2018 - 2022

          3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Therapeutic Class, 2023 - 2030

               3.5.3.1. Non-Hormonal Medical Treatment

               3.5.3.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

               3.5.3.3. Non-Selective Nsaids

               3.5.3.4. Cox-2 Inhibitors

               3.5.3.5. Transdermal Glyceryl Trinitrate

               3.5.3.6. Over-The-Counter (Otc) Medications

               3.5.3.7. Hormonal Medicine Treatment

               3.5.3.8. Combined Oral Contraceptive

               3.5.3.9. Progestin Regimens

               3.5.3.10. Levonorgestrel Intrauterine System (LN-IUS)

               3.5.3.11. Surgical Options

               3.5.3.12. Laparoscopy

               3.5.3.13. Hysterectomy

               3.5.3.14. Presacral Neurectomy

               3.5.3.15. Laparoscopic Uterosacral Nerve Ablation (LUNA)

               3.5.3.16. Intrauterine Device (IUD)

     3.6. Market Attractiveness Analysis: Therapeutic Class

4. Global Dysmenorrhea Treatment Market Outlook: Region

     4.1. Key Highlights

     4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022

     4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030

          4.3.1. North America

          4.3.2. Europe

          4.3.3. East Asia

          4.3.4. South Asia and Oceania

          4.3.5. Latin America

          4.3.6. Middle East & Africa (MEA)

     4.4. Market Attractiveness Analysis: Region

5. North America Dysmenorrhea Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

     5.1. Key Highlights

     5.2. Pricing Analysis

     5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

          5.3.1. By Country

          5.3.2. By Disease

          5.3.3. By Therapeutic Class

     5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

          5.4.1. U.S.

          5.4.2. Canada

     5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease, 2023 - 2030

          5.5.1. Primary Dysmenorrhea

          5.5.2. Secondary Dysmenorrhea

          5.5.3. Endometriosis

          5.5.4. Adenomyosis

          5.5.5. Uterine Myomas

          5.5.6. Endometrial Polyps

          5.5.7. Cervical Stenosis

          5.5.8. Obstructive Malformations of Genital Tract

     5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Therapeutic Class, 2023 - 2030

          5.6.1. Non-Hormonal Medical Treatment

          5.6.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

          5.6.3. Non-Selective Nsaids

          5.6.4. Cox-2 Inhibitors

          5.6.5. Transdermal Glyceryl Trinitrate

          5.6.6. Over-The-Counter (Otc) Medications

          5.6.7. Hormonal Medicine Treatment

          5.6.8. Combined Oral Contraceptive

          5.6.9. Progestin Regimens

          5.6.10. Levonorgestrel Intrauterine System (LN-IUS)

          5.6.11. Surgical Options

          5.6.12. Laparoscopy

          5.6.13. Hysterectomy

          5.6.14. Presacral Neurectomy

          5.6.15. Laparoscopic Uterosacral Nerve Ablation (LUNA)

          5.6.16. Intrauterine Device (IUD)

     5.7. Market Attractiveness Analysis

6. Europe Dysmenorrhea Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

     6.1. Key Highlights

     6.2. Pricing Analysis

     6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

          6.3.1. By Country

          6.3.2. By Disease

          6.3.3. By Therapeutic Class

     6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

          6.4.1. Germany

          6.4.2. France

          6.4.3. U.K.

          6.4.4. Italy

          6.4.5. Spain

          6.4.6. Russia

          6.4.7. Türkiye

          6.4.8. Rest of Europe

     6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease, 2023 - 2030

          6.5.1. Primary Dysmenorrhea

          6.5.2. Secondary Dysmenorrhea

          6.5.3. Endometriosis

          6.5.4. Adenomyosis

          6.5.5. Uterine Myomas

          6.5.6. Endometrial Polyps

          6.5.7. Cervical Stenosis

          6.5.8. Obstructive Malformations of Genital Tract

     6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Therapeutic Class, 2023 - 2030

          6.6.1. Non-Hormonal Medical Treatment

          6.6.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

          6.6.3. Non-Selective Nsaids

          6.6.4. Cox-2 Inhibitors

          6.6.5. Transdermal Glyceryl Trinitrate

          6.6.6. Over-The-Counter (Otc) Medications

          6.6.7. Hormonal Medicine Treatment

          6.6.8. Combined Oral Contraceptive

          6.6.9. Progestin Regimens

          6.6.10. Levonorgestrel Intrauterine System (LN-IUS)

          6.6.11. Surgical Options

          6.6.12. Laparoscopy

          6.6.13. Hysterectomy

          6.6.14. Presacral Neurectomy

          6.6.15. Laparoscopic Uterosacral Nerve Ablation (LUNA)

          6.6.16. Intrauterine Device (IUD)

     6.7. Market Attractiveness Analysis

7. East Asia Dysmenorrhea Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

     7.1. Key Highlights

     7.2. Pricing Analysis

     7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

          7.3.1. By Country

          7.3.2. By Disease

          7.3.3. By Therapeutic Class

     7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

          7.4.1. China

          7.4.2. Japan

          7.4.3. South Korea

     7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease, 2023 - 2030

          7.5.1. Primary Dysmenorrhea

          7.5.2. Secondary Dysmenorrhea

          7.5.3. Endometriosis

          7.5.4. Adenomyosis

          7.5.5. Uterine Myomas

          7.5.6. Endometrial Polyps

          7.5.7. Cervical Stenosis

          7.5.8. Obstructive Malformations of Genital Tract

     7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Therapeutic Class, 2023 - 2030

          7.6.1. Non-Hormonal Medical Treatment

          7.6.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

          7.6.3. Non-Selective Nsaids

          7.6.4. Cox-2 Inhibitors

          7.6.5. Transdermal Glyceryl Trinitrate

          7.6.6. Over-The-Counter (Otc) Medications

          7.6.7. Hormonal Medicine Treatment

          7.6.8. Combined Oral Contraceptive

          7.6.9. Progestin Regimens

          7.6.10. Levonorgestrel Intrauterine System (LN-IUS)

          7.6.11. Surgical Options

          7.6.12. Laparoscopy

          7.6.13. Hysterectomy

          7.6.14. Presacral Neurectomy

          7.6.15. Laparoscopic Uterosacral Nerve Ablation (LUNA)

          7.6.16. Intrauterine Device (IUD)

     7.7. Market Attractiveness Analysis

8. South Asia & Oceania Dysmenorrhea Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

     8.1. Key Highlights

     8.2. Pricing Analysis

     8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

          8.3.1. By Country

          8.3.2. By Disease

          8.3.3. By Therapeutic Class

     8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

          8.4.1. India

          8.4.2. Southeast Asia

          8.4.3. ANZ

          8.4.4. Rest of South Asia & Oceania

     8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease, 2023 - 2030

          8.5.1. Primary Dysmenorrhea

          8.5.2. Secondary Dysmenorrhea

          8.5.3. Endometriosis

          8.5.4. Adenomyosis

          8.5.5. Uterine Myomas

          8.5.6. Endometrial Polyps

          8.5.7. Cervical Stenosis

          8.5.8. Obstructive Malformations of Genital Tract

     8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Therapeutic Class, 2023 - 2030

          8.6.1. Non-Hormonal Medical Treatment

          8.6.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

          8.6.3. Non-Selective Nsaids

          8.6.4. Cox-2 Inhibitors

          8.6.5. Transdermal Glyceryl Trinitrate

          8.6.6. Over-The-Counter (Otc) Medications

          8.6.7. Hormonal Medicine Treatment

          8.6.8. Combined Oral Contraceptive

          8.6.9. Progestin Regimens

          8.6.10. Levonorgestrel Intrauterine System (LN-IUS)

          8.6.11. Surgical Options

          8.6.12. Laparoscopy

          8.6.13. Hysterectomy

          8.6.14. Presacral Neurectomy

          8.6.15. Laparoscopic Uterosacral Nerve Ablation (LUNA)

          8.6.16. Intrauterine Device (IUD)

     8.7. Market Attractiveness Analysis

9. Latin America Dysmenorrhea Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

     9.1. Key Highlights

     9.2. Pricing Analysis

     9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

          9.3.1. By Country

          9.3.2. By Disease

          9.3.3. By Therapeutic Class

     9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

          9.4.1. Brazil

          9.4.2. Mexico

          9.4.3. Rest of Latin America

     9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease, 2023 - 2030

          9.5.1. Primary Dysmenorrhea

          9.5.2. Secondary Dysmenorrhea

          9.5.3. Endometriosis

          9.5.4. Adenomyosis

          9.5.5. Uterine Myomas

          9.5.6. Endometrial Polyps

          9.5.7. Cervical Stenosis

          9.5.8. Obstructive Malformations of Genital Tract

     9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Therapeutic Class, 2023 - 2030

          9.6.1. Non-Hormonal Medical Treatment

          9.6.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

          9.6.3. Non-Selective Nsaids

          9.6.4. Cox-2 Inhibitors

          9.6.5. Transdermal Glyceryl Trinitrate

          9.6.6. Over-The-Counter (Otc) Medications

          9.6.7. Hormonal Medicine Treatment

          9.6.8. Combined Oral Contraceptive

          9.6.9. Progestin Regimens

          9.6.10. Levonorgestrel Intrauterine System (LN-IUS)

          9.6.11. Surgical Options

          9.6.12. Laparoscopy

          9.6.13. Hysterectomy

          9.6.14. Presacral Neurectomy

          9.6.15. Laparoscopic Uterosacral Nerve Ablation (LUNA)

          9.6.16. Intrauterine Device (IUD)

     9.7. Market Attractiveness Analysis

10. Middle East & Africa Dysmenorrhea Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

     10.1. Key Highlights

     10.2. Pricing Analysis

     10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

          10.3.1. By Country

          10.3.2. By Disease

          10.3.3. By Therapeutic Class

     10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

          10.4.1. GCC

          10.4.2. Egypt

          10.4.3. South Africa

          10.4.4. Northern Africa

          10.4.5. Rest of Middle East & Africa

     10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease, 2023 - 2030

          10.5.1. Primary Dysmenorrhea

          10.5.2. Secondary Dysmenorrhea

          10.5.3. Endometriosis

          10.5.4. Adenomyosis

          10.5.5. Uterine Myomas

          10.5.6. Endometrial Polyps

          10.5.7. Cervical Stenosis

          10.5.8. Obstructive Malformations of Genital Tract

     10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Therapeutic Class, 2023 - 2030

          10.6.1. Non-Hormonal Medical Treatment

          10.6.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

          10.6.3. Non-Selective Nsaids

          10.6.4. Cox-2 Inhibitors

          10.6.5. Transdermal Glyceryl Trinitrate

          10.6.6. Over-The-Counter (Otc) Medications

          10.6.7. Hormonal Medicine Treatment

          10.6.8. Combined Oral Contraceptive

          10.6.9. Progestin Regimens

          10.6.10. Levonorgestrel Intrauterine System (LN-IUS)

          10.6.11. Surgical Options

          10.6.12. Laparoscopy

          10.6.13. Hysterectomy

          10.6.14. Presacral Neurectomy

          10.6.15. Laparoscopic Uterosacral Nerve Ablation (LUNA)

          10.6.16. Intrauterine Device (IUD)

     10.7. Market Attractiveness Analysis

11. Competition Landscape

     11.1. Market Share Analysis, 2022

     11.2. Market Structure

          11.2.1. Competition Intensity Mapping By Market

          11.2.2. Competition Dashboard

          11.2.3. Apparent Product Capacity

     11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

          11.3.1. Novartis Pharmaceuticals Corporation

               11.3.1.1. Overview

               11.3.1.2. Segments and Product

               11.3.1.3. Key Financials

               11.3.1.4. Market Developments

               11.3.1.5. Market Strategy

          11.3.2. Merck, Inc.

               11.3.2.1. Overview

               11.3.2.2. Segments and Product

               11.3.2.3. Key Financials

               11.3.2.4. Market Developments

               11.3.2.5. Market Strategy

          11.3.3. Bayer Schering Pharma AG

               11.3.3.1. Overview

               11.3.3.2. Segments and Product

               11.3.3.3. Key Financials

               11.3.3.4. Market Developments

               11.3.3.5. Market Strategy

          11.3.4. Vanita Therapeutics

               11.3.4.1. Overview

               11.3.4.2. Segments and Product

               11.3.4.3. Key Financials

               11.3.4.4. Market Developments

               11.3.4.5. Market Strategy

          11.3.5. Alvogen

               11.3.5.1. Overview

               11.3.5.2. Segments and Product

               11.3.5.3. Key Financials

               11.3.5.4. Market Developments

               11.3.5.5. Market Strategy

          11.3.6. Pfizer, Inc.

               11.3.6.1. Overview

               11.3.6.2. Segments and Product

               11.3.6.3. Key Financials

               11.3.6.4. Market Developments

               11.3.6.5. Market Strategy

          11.3.7. Nua

               11.3.7.1. Overview

               11.3.7.2. Segments and Product

               11.3.7.3. Key Financials

               11.3.7.4. Market Developments

               11.3.7.5. Market Strategy

          11.3.8. Cora

               11.3.8.1. Overview

               11.3.8.2. Segments and Product

               11.3.8.3. Key Financials

               11.3.8.4. Market Developments

               11.3.8.5. Market Strategy

          11.3.9. Roche Laboratories

               11.3.9.1. Overview

               11.3.9.2. Segments and Product

               11.3.9.3. Key Financials

               11.3.9.4. Market Developments

               11.3.9.5. Market Strategy

          11.3.10. Taj Pharmaceuticals, Ltd.

               11.3.10.1. Overview

               11.3.10.2. Segments and Product

               11.3.10.3. Key Financials

               11.3.10.4. Market Developments

               11.3.10.5. Market Strategy

          11.3.11. Sanofi

               11.3.11.1. Overview

               11.3.11.2. Segments and Product

               11.3.11.3. Key Financials

               11.3.11.4. Market Developments

               11.3.11.5. Market Strategy

          11.3.12. Terramedic, Inc.

               11.3.12.1. Overview

               11.3.12.2. Segments and Product

               11.3.12.3. Key Financials

               11.3.12.4. Market Developments

               11.3.12.5. Market Strategy

12. Appendix

     12.1. Research Methodology

     12.2. Research Assumptions

     12.3. Acronyms and Abbreviations

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

- List Of Table -

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate